Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Kirisits

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 5, 2021
Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysisSofia Spampinato, Lars U Fokdal, Richard Pötter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 16, 2020
Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysisSofia Spampinato, Lars U Fokdal, Richard Pötter, et al.
International Journal of Radiation Oncology, Biology, Physics|October 17, 2020
Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I StudyNina B K Jensen, Richard Pötter, Sofia Spampinato, et al.
International Journal of Radiation Oncology, Biology, Physics|January 14, 2023
Overall Severe Morbidity After Chemo-Radiation Therapy and Magnetic Resonance Imaging-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I StudyAnders Schwartz Vittrup, Kathrin Kirchheiner, Richard Pötter, et al.
Clinical and Translational Radiation Oncology|March 30, 2018
The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studiesRichard Pötter, Kari Tanderup, Christian Kirisits, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2022
Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I StudyJacob Christian Lindegaard, Primoz Petric, Maximilian Paul Schmid, et al.
The Lancet. Oncology|April 1, 2021
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort studyRichard Pötter, Kari Tanderup, Maximilian Paul Schmid, et al.
International Journal of Radiation Oncology, Biology, Physics|May 12, 2025
Distant Metastasis After Chemoradiation and Image Guided Adaptive Brachytherapy in Locally Advanced Cervical CancerJohannes Knoth, Remi A Nout, Richard Pötter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2023
Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I StudyMaximilian P Schmid, Jacob C Lindegaard, Umesh Mahantshetty, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 4, 2021
Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: An EMBRACE analysisMax Peters, Astrid A C de Leeuw, Christel N Nomden, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 5, 2021
Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysisSofia Spampinato, Lars U Fokdal, Richard Pötter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 16, 2020
Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysisSofia Spampinato, Lars U Fokdal, Richard Pötter, et al.
International Journal of Radiation Oncology, Biology, Physics|October 17, 2020
Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I StudyNina B K Jensen, Richard Pötter, Sofia Spampinato, et al.
International Journal of Radiation Oncology, Biology, Physics|January 14, 2023
Overall Severe Morbidity After Chemo-Radiation Therapy and Magnetic Resonance Imaging-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I StudyAnders Schwartz Vittrup, Kathrin Kirchheiner, Richard Pötter, et al.
Clinical and Translational Radiation Oncology|March 30, 2018
The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studiesRichard Pötter, Kari Tanderup, Christian Kirisits, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2022
Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I StudyJacob Christian Lindegaard, Primoz Petric, Maximilian Paul Schmid, et al.
The Lancet. Oncology|April 1, 2021
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort studyRichard Pötter, Kari Tanderup, Maximilian Paul Schmid, et al.
International Journal of Radiation Oncology, Biology, Physics|May 12, 2025
Distant Metastasis After Chemoradiation and Image Guided Adaptive Brachytherapy in Locally Advanced Cervical CancerJohannes Knoth, Remi A Nout, Richard Pötter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2023
Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I StudyMaximilian P Schmid, Jacob C Lindegaard, Umesh Mahantshetty, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 4, 2021
Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: An EMBRACE analysisMax Peters, Astrid A C de Leeuw, Christel N Nomden, et al.
Pageof 18